Alzinova Q1’21: Short Comment

Alzinova’s interim report came without any surprises. We are in standby mode, where we are ready to review the case thoroughly in conjunction with clinical start.

AH

Anders Hedlund

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.